PM360

NOVEMBER 14, 2023

In March of this year the three largest insulin manufacturers announced a dramatic reduction in the price of many commonly prescribed insulins and a monthly out-of-pocket (OOP) cap of $35 that went into effect in May. The price is available to cash-paying patients with a valid prescription. for only $35. for only $35. of the U.S.

Retail 52

Retail Pharmaceutical manufacturing Sales Insurance 52

European Pharmaceutical Review

NOVEMBER 8, 2022

Pharmaceutical manufacturers have submitted Citizen Petitions raising safety or efficacy concerns about proposed competing generic and biosimilar products, and such submissions often delay FDA approval of the proposed products while the FDA resolves the pending petitions. Conclusion.

Food and Drug Administration 52

Food and Drug Administration Pharma Prescription Manufacturing 52

Prognos Health

MAY 31, 2023

Todd Somsel , Commercial Lead, RWD Marketplace The acceptance and application of real-world evidence (RWE) by stakeholders across the healthcare industry continues its rapid pace of growth. One of the key pillars of understanding is in the quality of the evidence, and its underlying real-world data (RWD).

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Specialization Manufacturing Healthcare 52

European Pharmaceutical Review

OCTOBER 12, 2023

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Kerry, Ireland.

Pharmaceutical manufacturing 84

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharma 84

Pharmaceutical Technology

SEPTEMBER 13, 2022

Additionally, it aids clients in introducing products to international markets and varied patient populations by delivering tech-driven services spanning from clinical development consultation to marketing authorisation. The post AmerisourceBergen agrees to acquire PharmaLex for $1.29bn appeared first on Pharmaceutical Technology.

Biopharma 52

Biopharma Manufacturing Pharmaceutical manufacturing Consulting 52

PM360

AUGUST 9, 2022

How can we help ensure patients continue to take their medications as prescribed? The reasons why a patient may not take their medication are plentiful, and as a result so are the solutions now available to attempt to solve this issue. But it is not a simple answer. Furthermore, it is estimated to reach $6.5

Prescription 105

Prescription Medical Side effects Patients 105

PM360

DECEMBER 20, 2023

Given China’s status as the world’s second most populous nation and an economic powerhouse, it represents both a monumental market opportunity and a dynamic arena of challenges for pharmaceutical products. In 2021, the out-of-pocket (OOP) cost accounts for 28% of the whole healthcare expenses compared to 15.4% billion people in 2023).

Marketing 105

Marketing Insurance Medical Manufacturing 105

Clarify Health

OCTOBER 26, 2021

By enrolling participants with a wide range of baseline characteristics, study populations will more accurately reflect the patients likely to take the drug if it is approved. Cancer patients treated in clinical trials live substantially longer than those not treated in trials and benefit from lower hospital readmissions. 2] Figure 1.

Food and Drug Administration 52

Food and Drug Administration Recruitment Pharmaceutical manufacturing Medical 52

Clarivate

MARCH 14, 2024

Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1] Manufacturers, healthcare providers, and consumers alike face the need to quickly adapt.

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

Pharma Marketing Network

JUNE 11, 2020

RJ Lewis (EHS): Hello, this is RJ Lewis and we’re back for Episode 2 with John Mack and Don Langsdorf, and we’re talking about the rebirth of Pharma Marketing and Pharma Guy. So, you continue with Pharma Marketing news. Where do you see it going? RJ Lewis (EHS): So, thanks for that question. That’s our vision.

Pharma 52

Pharma Marketing Media Healthcare 52

Impetus Digital

MARCH 14, 2023

When we think of adherence in the medical world, it’s often simplified to something along the lines of the degree to which a patient correctly follows medical advice. It’s a simple statement with many, many moving parts, especially when we’re talking about patients with multiple chronic conditions. So how is this achieved?

Patients 102

Patients Management Medical Pharmaceutical manufacturing 102

PM360

MAY 21, 2024

Manufacturer assistance programs are designed to make treatments more affordable, yet only about 10% of these dollars are used by patients. The cost of filling a prescription can keep 21% of patients from getting an Rx, and one in ten patients will modify their treatment plan because of cost, according to recent polling data from KFF.

Electronics 52

Electronics Prescription Pharmaceutical manufacturing Patients 52

European Pharmaceutical Review

DECEMBER 18, 2023

For example, due to prevalence of the disease across the globe, US approval of the biologic lecanemab was particularly anticipated by both the industry and patients. The findings were published in the NEMJ in April 2023 and demonstrated “the best solid tumour CAR-T data reported to date – and by a country mile!

Manufacturing 96

Manufacturing Food and Drug Administration Medicine Pharmaceutical manufacturing 96

World of DTC Marketing

DECEMBER 10, 2020

SUMMARY: (JAMA) The median drug wholesale list price (as defined by Average Wholesale Price) increased by 129% from 2010-2016, while median patient out-of-pocket costs increased by 53% and median insurance payments after rebates and discounts increased by 64%. The Pharma Spin. Say goodbye to all the supposed goodwill.

Insurance 181

Insurance Pharma Manufacturing Retail 181

Impetus Digital

NOVEMBER 23, 2023

Many of these will discuss the expanding role and capabilities of AI and machine learning in the Pharma space. The new way to engage KOLs at conferences: virtual Ambassador programs To start off the top-5, let’s take a look at how Pharma is shifting the way they engage key opinion leaders (KOLs) at medical congresses and conferences.

Education 52

Education Healthcare Provider Physicians Pharma 52

European Pharmaceutical Review

JULY 25, 2022

To appreciate the scope of the challenge facing the pharmaceutical market, as well as patients across the globe, we must understand that there are two distinct threats – ‘counterfeit’ and ‘falsified’ medicines. The latest on pharmaceutical counterfeiting… An industry growing in pharma’s shadow. trillion 3 worldwide.

Pharmaceutical 82

Pharmaceutical Medicine Pharmaceutical manufacturing Manufacturing 82

pharmaphorum

SEPTEMBER 30, 2022

This shift enables companies to improve the quality and compliance of the documents and data that make up regulatory submissions and create a data-sharing ecosystem that enhances healthcare. Over the years, pharmaceutical companies seeking product approvals have submitted increasingly vast amounts of information to regulatory agencies.

Management 52

Management Pharmaceutical Marketing Electronics 52